Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Digital Health Meets AI -CSE: ALEN.U (click to learn more) New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF) (click to learn more) Why Herbal Dispatch (CSE:HERB) Is Getting Attention (click to learn more) Atlas Salt Expands MOU with Sandvik Mining Supporting Great Atlantic Salt Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Stevanato Group SpA STVN

Healthcare Biotechnology
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:STVN)

Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025

Business Wire November 6, 2025

Stevanato Group to Participate in Upcoming Investor Conferences

Business Wire October 31, 2025

Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025

Business Wire October 22, 2025

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings

Business Wire October 21, 2025

Stevanato Group to Participate in Upcoming Investor Conferences

Business Wire September 2, 2025

Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025

Business Wire August 5, 2025

Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.

Business Wire July 23, 2025

Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025

Business Wire July 22, 2025

Stevanato Group to Participate in Upcoming Investor Conferences

Business Wire May 9, 2025
View More News ››

Opinion & Analysis (NYSE:STVN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:STVN)

Be the first to post on this bullboard.

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp., an exploration stage company, engages in the acquisition and exploration of mineral ...
View More »

Podcasts